BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36795488)

  • 1. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.
    Gimple RC; Zhang G; Wang S; Huang T; Lee J; Taori S; Lv D; Dixit D; Halbert ME; Morton AR; Kidwell RL; Dong Z; Prager BC; Kim LJ; Qiu Z; Zhao L; Xie Q; Wu Q; Agnihotri S; Rich JN
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe.
    Zhang G; Dong Z; Gimple RC; Wolin A; Wu Q; Qiu Z; Wood LM; Shen JZ; Jiang L; Zhao L; Lv D; Prager BC; Kim LJY; Wang X; Zhang L; Anderson RL; Moore JK; Bao S; Keller TH; Lin G; Kang C; Hamerlik P; Zhao R; Ford HL; Rich JN
    J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34617969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
    Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
    Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived glioblastoma stem cells respond differentially to targeted therapies.
    Kanabur P; Guo S; Simonds GR; Kelly DF; Gourdie RG; Verbridge SS; Sheng Z
    Oncotarget; 2016 Dec; 7(52):86406-86419. PubMed ID: 27863440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC.
    Zhang S; Yang Z; Bao W; Liu L; You Y; Wang X; Shao L; Fu W; Kou X; Shen W; Yuan C; Hu B; Dang W; Nandakumar KS; Jiang H; Zheng M; Shen X
    Autophagy; 2020 Apr; 16(4):735-749. PubMed ID: 31208298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REST regulates oncogenic properties of glioblastoma stem cells.
    Kamal MM; Sathyan P; Singh SK; Zinn PO; Marisetty AL; Liang S; Gumin J; El-Mesallamy HO; Suki D; Colman H; Fuller GN; Lang FF; Majumder S
    Stem Cells; 2012 Mar; 30(3):405-14. PubMed ID: 22228704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
    Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN
    Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
    Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
    Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.
    Kim Y; Kim E; Wu Q; Guryanova O; Hitomi M; Lathia JD; Serwanski D; Sloan AE; Weil RJ; Lee J; Nishiyama A; Bao S; Hjelmeland AB; Rich JN
    Genes Dev; 2012 Jun; 26(11):1247-62. PubMed ID: 22661233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF signaling inhibits mitophagy in glioblastoma stem cells through N
    Lv D; Gimple RC; Zhong C; Wu Q; Yang K; Prager BC; Godugu B; Qiu Z; Zhao L; Zhang G; Dixit D; Lee D; Shen JZ; Li X; Xie Q; Wang X; Agnihotri S; Rich JN
    Dev Cell; 2022 Jun; 57(12):1466-1481.e6. PubMed ID: 35659339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting A20 decreases glioma stem cell survival and tumor growth.
    Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
    PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
    J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.